HeartMate 3 recall and insufficient hearts for transplant make HF therapy landscape dire: GlobalData According to GlobalData, there were over 7.8 million prevalent cases of HF in the US alone in 2023, registering a CAGR of 2 per…
HeartMate 3 can impact treatment options for patients with end stage heartfailure According to GlobalData, the device also demonstrated reduced hospitalisation time and vastly reduced blood clotting
